Investigation Report on China Quetiapine Market, 2010-2019
Description
WHO estimated that the lifetime prevalence of schizophrenia is about 3.8%-8.4% in the world. According to the statistics published by National Center for Mental Health in 2014, the number of people with mental disorders is above 100 million. Suppose the mainland population was 1368 million, the number of people with schizophrenia shall be about 17.8 million. Symptoms of schizophrenia begin earlier in men than in women and are more common to see in men than in women. The risk of dying young in schizophrenia patients is 2 to 2.5 times that in common people. This is the result of increased physical health problems like cardiovascular, metabolic and epidemic diseases. Take diabetes for example, its incidence among schizophrenia patients is 2-3 times that in common people.
Developed by AstraZeneca plc., quetiapine (under the trade name of Seroquel) is an important drug for the treatment of schizophrenia. Approved by CFDA to treat schizophrenia in 2000, quetiapine was listed in the Catalogue of Drugs for the Basic National Medical Insurance in 2014. Currently, local manufacturers of quetiapine are Hunan Dongting Pharmaceutical Co., Ltd and Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory, the former owning relevant patent for quetiapine compound according to CFDA.
Quetiapine develops fast after entering China, sales value reaching CNY 116 million in 2013 and CNY 131 million in 2014 with a year-on-year growth of 12.93% and CAGR reaching 9.72% during the period of 2010-2014. With accelerating pace of life and increased life pressure, the incidence of mental disorder keeps going up, which fosters the vast demand for quetiapine in China. Currenly, Hunan Dongting Pharmaceutical Co., Ltd, Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory and AstraZeneca plc. occupy the majority of market share, among which AstraZeneca plc. had the largest share of 78.50% for sales value in 2014. As local enterprises have patented quetiapine compound and sold it at a relatively low price, their market share is expected to expand in the next few years.
Readers can get at least the following information from this report:
WHO estimated that the lifetime prevalence of schizophrenia is about 3.8%-8.4% in the world. According to the statistics published by National Center for Mental Health in 2014, the number of people with mental disorders is above 100 million. Suppose the mainland population was 1368 million, the number of people with schizophrenia shall be about 17.8 million. Symptoms of schizophrenia begin earlier in men than in women and are more common to see in men than in women. The risk of dying young in schizophrenia patients is 2 to 2.5 times that in common people. This is the result of increased physical health problems like cardiovascular, metabolic and epidemic diseases. Take diabetes for example, its incidence among schizophrenia patients is 2-3 times that in common people.
Developed by AstraZeneca plc., quetiapine (under the trade name of Seroquel) is an important drug for the treatment of schizophrenia. Approved by CFDA to treat schizophrenia in 2000, quetiapine was listed in the Catalogue of Drugs for the Basic National Medical Insurance in 2014. Currently, local manufacturers of quetiapine are Hunan Dongting Pharmaceutical Co., Ltd and Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory, the former owning relevant patent for quetiapine compound according to CFDA.
Quetiapine develops fast after entering China, sales value reaching CNY 116 million in 2013 and CNY 131 million in 2014 with a year-on-year growth of 12.93% and CAGR reaching 9.72% during the period of 2010-2014. With accelerating pace of life and increased life pressure, the incidence of mental disorder keeps going up, which fosters the vast demand for quetiapine in China. Currenly, Hunan Dongting Pharmaceutical Co., Ltd, Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory and AstraZeneca plc. occupy the majority of market share, among which AstraZeneca plc. had the largest share of 78.50% for sales value in 2014. As local enterprises have patented quetiapine compound and sold it at a relatively low price, their market share is expected to expand in the next few years.
Readers can get at least the following information from this report:
- market size of quetiapine in China
- retail price of quetiapine in China
- market outlook of quetiapine in China
- manufacturers of antipsychotics
- investors/ research institutions interested in Chinese medicine market
- any interest in the medicine market, please contact CRI for customized survey service
1 RELATED CONCEPTS OF QUETIAPINE
1.1 Indication
1.2 Sales Status in Global Market
2 MARKET PROFILE OF QUETIAPINE IN CHINA
2.1 Patent Status and Approval Information of Quetiapine in China
2.2 Major Manufacturers
2.3 Market Size
3 SURVEY ON SALES STATUS OF QUETIAPINE IN CHINA, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 SURVEY ON MARKET SHARE OF MAJOR MANUFACTURERS OF QUETIAPINE IN CHINA, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 SURVEY ON DOSAGE FORMS OF QUETIAPINE IN CHINA, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume
6 REFERENCE PRICE OF QUETIAPINE IN CHINESE HOSPITALS IN 2014
6.1 Hunan Dongting Pharmaceutical Co., Ltd (Trade Name: Qiwei)
6.2 Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory (Trade Name: Shuling)
6.3 AstraZeneca plc. (Trade Name: Seroquel)
7 MAJOR MANUFACTURERS OF QUETIAPINE IN CHINESE MARKET, 2010-2014
7.1 Hunan Dongting Pharmaceutical Co., Ltd
7.2 Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory
7.3 AstraZeneca plc.
8 MARKET OUTLOOK OF QUETIAPINE IN CHINA, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape
TABLE OF SELECTED CHARTS
Chart Patent Status of Quetiapine in China
Chart Approval Information of Quetiapine in China
Chart Sales Status of Quetiapine in China
Chart Sales Value of Quetiapine in China, 2010-2014
Chart Sales Value of Quetiapine in Some Regions in China, 2010-2014
Chart Sales Volume of Quetiapine in China, 2010-2014
Chart Sales Volume of Quetiapine in Some Regions in China, 2010-2014
Chart Market Share of TOP3 Manufacturers of Quetiapine by Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Quetiapine Made by Hunan Dongting Pharmaceutical Co., Ltd in China, 2010-2014
Chart Sales Value and Market Share of Quetiapine Made by Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory in China, 2010-2014
Chart Sales Value and Market Share of Quetiapine Made by AstraZeneca plc. in China, 2010-2014
Chart Price of Quetiapine Made by Hunan Dongting Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Quetiapine Made by Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory in Some Chinese Cities in 2014
Chart Price of Quetiapine Made by AstraZeneca plc. in Some Chinese Cities in 2014
COMPANIES MENTIONED
Hunan Dongting Pharmaceutical Co., Ltd; Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory; AstraZeneca plc.
1.1 Indication
1.2 Sales Status in Global Market
2 MARKET PROFILE OF QUETIAPINE IN CHINA
2.1 Patent Status and Approval Information of Quetiapine in China
2.2 Major Manufacturers
2.3 Market Size
3 SURVEY ON SALES STATUS OF QUETIAPINE IN CHINA, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions
4 SURVEY ON MARKET SHARE OF MAJOR MANUFACTURERS OF QUETIAPINE IN CHINA, 2010-2014
4.1 Market Share by Sales Value
4.2 Market Share by Sales Volume
5 SURVEY ON DOSAGE FORMS OF QUETIAPINE IN CHINA, 2010-2014
5.1 Share of Different Dosage Forms by Sales Value
5.2 Share of Different Dosage Forms by Sales Volume
6 REFERENCE PRICE OF QUETIAPINE IN CHINESE HOSPITALS IN 2014
6.1 Hunan Dongting Pharmaceutical Co., Ltd (Trade Name: Qiwei)
6.2 Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory (Trade Name: Shuling)
6.3 AstraZeneca plc. (Trade Name: Seroquel)
7 MAJOR MANUFACTURERS OF QUETIAPINE IN CHINESE MARKET, 2010-2014
7.1 Hunan Dongting Pharmaceutical Co., Ltd
7.2 Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory
7.3 AstraZeneca plc.
8 MARKET OUTLOOK OF QUETIAPINE IN CHINA, 2015-2019
8.1 Forecast of Market Size
8.2 Forecast of Competitive Landscape
TABLE OF SELECTED CHARTS
Chart Patent Status of Quetiapine in China
Chart Approval Information of Quetiapine in China
Chart Sales Status of Quetiapine in China
Chart Sales Value of Quetiapine in China, 2010-2014
Chart Sales Value of Quetiapine in Some Regions in China, 2010-2014
Chart Sales Volume of Quetiapine in China, 2010-2014
Chart Sales Volume of Quetiapine in Some Regions in China, 2010-2014
Chart Market Share of TOP3 Manufacturers of Quetiapine by Sales Value in China, 2010-2014
Chart Sales Value and Market Share of Quetiapine Made by Hunan Dongting Pharmaceutical Co., Ltd in China, 2010-2014
Chart Sales Value and Market Share of Quetiapine Made by Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory in China, 2010-2014
Chart Sales Value and Market Share of Quetiapine Made by AstraZeneca plc. in China, 2010-2014
Chart Price of Quetiapine Made by Hunan Dongting Pharmaceutical Co., Ltd in Some Chinese Cities in 2014
Chart Price of Quetiapine Made by Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory in Some Chinese Cities in 2014
Chart Price of Quetiapine Made by AstraZeneca plc. in Some Chinese Cities in 2014
COMPANIES MENTIONED
Hunan Dongting Pharmaceutical Co., Ltd; Suzhou Pharmaceutical Group Co., Ltd. No.1 Pharmaceutical Factory; AstraZeneca plc.
